How to develop viruses into anticancer weapons
PLoS Pathog
.
2017 Mar 16;13(3):e1006190.
doi: 10.1371/journal.ppat.1006190.
eCollection 2017 Mar.
Authors
Roberto Cattaneo
1
,
Stephen J Russell
1
Affiliation
1
Department of Molecular Medicine and Virology and Gene Therapy Graduate School track, Mayo Clinic, Rochester, Minnesota, United States of America.
PMID:
28301602
PMCID:
PMC5354445
DOI:
10.1371/journal.ppat.1006190
No abstract available
Publication types
Review
MeSH terms
Animals
Antineoplastic Agents / immunology
Antineoplastic Agents / pharmacology*
Humans
Oncolytic Virotherapy* / methods
Oncolytic Virotherapy* / trends
Oncolytic Viruses* / immunology
Substances
Antineoplastic Agents
Grants and funding
P50 CA186781/CA/NCI NIH HHS/United States